Cargando…
Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma
Despite great advances in the treatment of liver hepatocellular carcinoma (LIHC), such as immunotherapy, the prognosis remains extremely poor, and there is an urgent need to develop novel diagnostic and prognostic markers. Recently, RNA methylation-related long non-coding RNAs (lncRNAs) have been de...
Autores principales: | Wei, Wei, Liu, Chao, Wang, Meng, Jiang, Wei, Wang, Caihong, Zhang, Shuqun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354608/ https://www.ncbi.nlm.nih.gov/pubmed/35938009 http://dx.doi.org/10.3389/fgene.2022.906496 |
Ejemplares similares
-
Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response
por: Cao, Jin, et al.
Publicado: (2022) -
Comprehensive pan-cancer analysis of N7-methylguanosine regulators: Expression features and potential implications in prognosis and immunotherapy
por: Wei, Wei, et al.
Publicado: (2022) -
N7-methylguanosine-related lncRNAs: Predicting the prognosis and diagnosis of colorectal cancer in the cold and hot tumors
por: Wu, Jing-Yu, et al.
Publicado: (2022) -
Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma
por: Li, Yilin, et al.
Publicado: (2023) -
N7-Methylguanosine-Related lncRNAs: Integrated Analysis Associated With Prognosis and Progression in Clear Cell Renal Cell Carcinoma
por: Ming, Jie, et al.
Publicado: (2022)